• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Insys Therapeutics Inc

+ Add to Watchlist

INSY:US

40.6750 USD 1.3150 3.13%

As of 20:10:00 ET on 10/31/2014.

Snapshot for Insys Therapeutics Inc (INSY)

Open: 42.2800 Day's Range: 40.3150 - 43.0000 Volume: 365,035
Previous Close: 41.9900 52wk Range: 20.5200 - 57.9133 1-Yr Rtn: +46.20%

Stock Chart for INSY

No chart data available.
  • INSY:US 40.6750
  • 1D
  • 1M
  • 1Y
41.9900
Interactive INSY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INSY

Current P/E Ratio (ttm) 27.4213
Estimated P/E(12/2014) 27.0625
Relative P/E vs. SPX 1.5328
Earnings Per Share (USD) (ttm) 1.4833
Est. EPS (USD) (12/2014) 1.5030
Est. PEG Ratio 1.0613
Market Cap (M USD) 1,403.70
Shares Outstanding (M) 34.51
30 Day Average Volume 511,882
Price/Book (mrq) 11.5473
Price/Sale (ttm) 8.1186
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/11/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INSY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INSY

Insys Therapeutics, Inc. develops cancer support drugs. The Company's support care candidates include a fast-acting sublingual spray for cancer pain, and a dronabinol product used to treat chemotherapy-induced nausea and vomiting and to stimulate appetite in AIDS patients.

John N KapoorChairmanMichael L BabichPresident/CEO
Darryl S BakerChief Financial OfficerChristopher F HomrichSenior VP:Operations
More Company Profile & Key Executives for INSY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil